Sunday, 12 August 2012

Food And Drug Administration-Advanced Breast Cancer-Multiple Myeloma-Healthday News

Kyprolis Approved for Multiple Myeloma

FRIDAY, July 20 (Healthday News) -- Kyprolis (carfilzomib) has been approved by the U.S. Food and Drug Administration to treat certain people with multiple myeloma who have already been given at least two prior therapies. read more..


FDA Gives Nod to New Breast Cancer Drug

FRIDAY, July 20 (Healthday News) -- The U.S. Food and Drug Administration on Friday approved the use of the drug Afinitor (everolimus) for use by women with a particular form of advanced breast cancer. read more..

No comments:

Post a comment